MedTrace Logo

Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder

NCT04770285 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 386

Last updated 2024-10-16

Study results available
· View outcomes & findings →

Summary

This study compares the effectiveness of 2 digital therapeutics in adult participants diagnosed with major depressive disorder (MDD) who are on antidepressant therapy (ADT) monotherapy for the treatment of depression.

Conditions

Interventions

DEVICE

CT-152 - Digital Therapeutic

CT-152 mobile app was used by the participants as per the schedule specified in the respective arm.

DEVICE

Sham

Sham mobile app was used by the participants as per the schedule specified in the respective arm.

Sponsors & Collaborators

  • Click Therapeutics, Inc.

    collaborator INDUSTRY

  • Otsuka Pharmaceutical Development & Commercialization, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-25
Primary Completion
2022-10-26
Completion
2022-10-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04770285 on ClinicalTrials.gov